Evidence map›Paper›PMID 39104135›Full record

Observational studyEuropean journal of neurology2024

Association of serum uric acid to serum creatinine ratio with 1-year stroke outcomes in patients with acute ischemic stroke: A multicenter observational cohort study.

Dandan Zhang, Zhongzhong Liu, Weiyan Guo, Qingli Lu, Zhen Lei, Pei Liu, Tong Liu, Linna Peng, Qiaoqiao Chang, Mi Zhang and 3 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in European journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dandan ZhangDepartment of Neurology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, China.
Zhongzhong LiuDepartment of Neurology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, China.
Weiyan GuoXi'an Key Laboratory for Innovation and Translation of Neuroimmunological Diseases, Xi'an, China.
Qingli LuDepartment of Neurology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, China.
Zhen LeiCollege of Life Science, Northwest University, Xi'an, China.
Pei LiuDepartment of Neurology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, China.
Tong LiuDepartment of Neurology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, China.
Linna PengDepartment of Neurology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, China.
Qiaoqiao ChangDepartment of Neurology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, China.
Mi ZhangDepartment of Neurology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, China.
Xuemei LinDepartment of Neurology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, China.
Fang WangDepartment of Neurology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, China.
Songdi WuDepartment of Neurology, Xi'an No. 1 Hospital, First Affiliated Hospital of Northwest University, Xi'an, China.ORCID 0000-0003-1186-3322

Funding

the Project of Shaanxi Administration of Traditional Chinese Medicine Grant no. 2022-SLRH-LJ-013the Science and Technology Program of Shaanxi Province Grant no. 2022SF-381the Science and Technology Program of Shaanxi Province Grant no. 2022SF-507the Science and Technology Program of Shaanxi Province Grant no.2023-YBSF-041the Science and Technology Program of Xi'an City Grant no. 22YXYJ0061the Science and Technology Program of Xi'an City Grant no. 22YXYJ0074the Science and Technology Program of Xi'an City Grant no. 24YXYJ0081the Scientific Research Project of the Shaanxi Health Commission Grant no. 2022C005the Scientific Research Project of the Xi'an Health Commission Grant no. 2020ms03the Scientific Research Project of the Xi'an Health Commission Grant no. 2021yb33the Scientific Research Project of the Xi'an Health Commission Grant no. 2022qn11Xi'an City Major Project-Discipline Capacity Building Grant no. 23YXYJ0005
6 · The paper itself

Abstract

background and purposeConsidering the reliance of serum uric acid (SUA) levels on renal clearance function, its role in stroke outcomes remains controversial. This study investigated the association of renal function-normalized SUA (SUA to serum creatinine ratio, SUA/SCr), a novel renal function index, with the 1-year outcomes in patients with acute ischemic stroke (AIS).

methodsThis is a prospective, multicenter observational study. Renal function-normalized SUA levels were determined by calculating the ratio of SUA to SCr. One-year outcomes included stroke recurrence, all-cause mortality, and poor prognosis. Multivariable Cox regression analyses and restriction cubic splines for curve fitting were used to evaluate SUA/SCr's association with 1-year stroke outcomes.

resultsAmong 2294 enrolled patients, after adjustment for potential confounders, multivariable Cox regression analyses showed that each one-unit increase in SUA/SCr corresponded to a 19% decrease in 1-year stroke recurrence in patients with AIS. SUA/SCr was analyzed as a continuous variable and categorized into quartiles (Q1-Q4). Compared with the Q1 reference group, Q2, Q3, and Q4 showed significantly lower 1-year stroke recurrence risks. The trend test indicated significant differences in the 1-year stroke recurrence trend from Q1 to Q4. In these patients, SUA/SCr did not show a significant association with poor prognosis or all-cause mortality. Curve fitting revealed SUA/SCr had a negative but nonlinear association with 1-year stroke recurrence.

conclusionsIn patients with AIS, low SUA/SCr may be an independent risk factor for 1-year stroke recurrence. Changes in SUA/SCr had no significant impact on 1-year poor prognosis and all-cause mortality.

Indexed as

CreatinineIschemic StrokeUric AcidAgedAged, 80 and overCohort StudiesFemaleHumansMaleMiddle AgedPrognosisProspective StudiesRecurrenceCreatinineUric Acidacute ischemic strokerenal functionserum creatinineserum uric acidstroke outcomes

Identifiers

PMID39104135
PMCPMC11555002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.